| abstract |
The invention discloses three 3H-imidazo[4,5-c]pyridine-6-formyl-NG-NO2-Arg-AA-OBzl as shown in a formula which is described in the specification (wherein AA in the formula is one selected from the group consisting of L-Thr, L-Ser and L-Asp(OBzl) residues), a preparation method thereof and tumor growth inhibition effect, anti-inflammatory activity and in-vivo antithrombotic activity of the same. Results show that 3H-imidazo[4,5-c]pyridine-6-formyl-NG-NO2-Arg-AA-OBzl is a compound with antineoplastic, anti-inflammatory and antithrombotic triactivity and has good clinical application prospects. |